InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,469.01
(
-0.33%
)
US TECH 100
19,245.20
(
-0.84%
)
Dow Jones
39,148.21
(
0.81%
)
Brent Oil
85.18
(
0.57%
)
Bitcoin
64,993.75
(
0.03%
)
Post# of 252268
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

bladerunner1717

Send PM Follow Ignore
Followers 38
Posts 5652
Boards Moderated 0
Alias Born 11/09/2003

bladerunner1717

Re: mcbio post# 112115

Wednesday, 01/12/2011 11:54:27 AM

Wednesday, January 12, 2011 11:54:27 AM

Post# of 252268
re: ZIOP

Dr. Mark Thornton returns to ZIOP.

Some of you may remember Dr. Thornton from his ill-fated GNVC days.




On Tuesday January 4, 2011, 7:53 am EST

NEW YORK (AP) -- Ziopharm Oncology Inc. said Tuesday that Mark O. Thornton has returned to the company to become executive vice president and chief development officer.

Thornton will report to CEO and Chief Medical Officer Jonathan Lewis and will oversee the product development process. The executive is rejoining New York-based Ziopharm after serving as medical officer at the Food and Drug Administration's Center for Biologics Evaluation and Research.

Thornton also previously served as Ziopharm's chief medical officer and head of product development.


Bladerunner
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up